CD55, a potential immunotherapeutic target forMYCN-amplified neuroblastoma is a research paper published in Neuro-Oncology (2022). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01CA255369
National Institutes of Health
Grant: 54CA243125
National Institutes of Health
Grant: R01NS106155
National Institutes of Health
Grant: R01CA159859
National Institutes of Health
Grant: R01CA221969
National Institutes of Health
Grant: P01CA217959
National Institutes of Health
Grant: P30CA82103
National Institutes of Health
Grant: P50CA097257
National Institutes of Health
Grant: U01CA217864
National Institutes of Health
Grant: 466710
FWCI
0.00
Citation Percentile
0.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals